Profil bibliographique

Jong‐Mu Sun

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

398Publications signalées

12462Citations signalées

2Affiliations récentes

Institutions déclarées

Samsung Medical Center Sungkyunkwan University

Domaines associés

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentColorectal Cancer Treatments and Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Mechanisms of Acquired Resistance and ctDNA Clearance in EGFR-Mutated Advanced NSCLC Following Lazertinib Treatment: Results From the Phase 3 LASER301 Study

Myung-Ju Ahn, Ki Hyeong Lee, Chin Heng Fong, Anastasia Zimina et autres

0 citationsJTO Clinical and Research Reports

Accès ouvert 2026 articleOpenAlex

Central Nervous System Activity of Lazertinib in EGFR ‐Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG‐LU20‐15 and LU21‐01

Dong Hyun Kim, Min Hee Hong, Hyun Ae Jung, Tae Min Kim et autres

0 citationsThoracic Cancer

Accès ouvert 2026 articleOpenAlex

Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study

Jinyong Kim, Sehhoon Park, Gyeong‐Won Lee, Il-Hwan Kim et autres

0 citationsJTO Clinical and Research Reports

Accès ouvert 2026 articleOpenAlex

Feasibility of mobile device-based patient-reported outcomes in real-world clinical settings for non-small cell lung cancer

Changgon Kim, Jinyong Kim, Byung-Ho Nam, J KIM et autres

0 citationsPrecision and Future Medicine

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S5 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S4 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S2 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Data from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S1 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S2 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S4 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Eun Ji Lee, Ji Ae Ko, Min-Je Kim, Jae Seok Cho et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.